Cargando…
A Literature Review of Ozanimod Therapy in Inflammatory Bowel Disease: From Concept to Practical Application
Inflammatory bowel disease (IBD), namely Ulcerative Colitis (UC) and Crohn’s Disease (CD), is believed to be due to a dysregulation of the innate immune response. The complexity of the immune cascade offers both a challenge and an opportunity to researchers seeking out new treatments for IBD, as var...
Autores principales: | Becher, Noah, Swaminath, Arun, Sultan, Keith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467694/ https://www.ncbi.nlm.nih.gov/pubmed/36106049 http://dx.doi.org/10.2147/TCRM.S336139 |
Ejemplares similares
-
Review of inflammatory bowel disease and COVID-19
por: Sultan, Keith, et al.
Publicado: (2020) -
Corticosteroid and Biologic Use Not Associated With Adverse Outcomes for Inflammatory Bowel Disease Patients Hospitalized With COVID-19
por: Sultan, Keith, et al.
Publicado: (2021) -
Ozanimod for multiple sclerosis
Publicado: (2021) -
COVID-19 Vaccination and Inflammatory Bowel Disease: Desired Antibody Responses, Future Directions, and a Note of Caution
por: Levine, Irving, et al.
Publicado: (2022) -
Ozanimod: A Review in Ulcerative Colitis
por: Paik, Julia
Publicado: (2022)